Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
Nicole G. Chau(University of British Columbia), Peter S. Hammerman(Broad Institute), Vickie Y. Jo(Brigham and Women's Hospital), Jonathan D. Schoenfeld(Brigham and Women's Hospital), Yvonne Y. Li(Broad Institute), Neal I. Lindeman(Cornell University), Laura A. Goguen(Brigham and Women's Hospital), Geoffrey I. Shapiro(Brigham and Women's Hospital), Don J. Annino(Brigham and Women's Hospital), Guilherme Rabinowits(Baptist Hospital of Miami), Hailey Becker(Dana-Farber Cancer Institute), Roy B. Tishler(Dana-Farber Cancer Institute), Jeffrey F. Krane(University of California, Los Angeles), Danielle N. Margalit(Harvard University), Tyler Haddad(Dana-Farber Cancer Institute), Robert I. Haddad(Georgetown University), Tom Thomas(Dana-Farber Cancer Institute), Jochen H. Lorch(Northwestern University)
Cited by 57
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k